Medtronic Statistics
Share Statistics
Medtronic has 1.28B shares outstanding. The number of shares has increased by -3.43% in one year.
| Shares Outstanding | 1.28B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.02% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.28B |
| Failed to Deliver (FTD) Shares | 36.88K |
| FTD / Avg. Volume | 0.64% |
Short Selling Information
The latest short interest is 10.18M, so 0.79% of the outstanding shares have been sold short.
| Short Interest | 10.18M |
| Short % of Shares Out | 0.79% |
| Short % of Float | 0.79% |
| Short Ratio (days to cover) | 2.19 |
Valuation Ratios
The PE ratio is 28.8 and the forward PE ratio is 15.09. Medtronic's PEG ratio is 0.39.
| PE Ratio | 28.8 |
| Forward PE | 15.09 |
| PS Ratio | 3.27 |
| Forward PS | 3 |
| PB Ratio | 2.11 |
| P/FCF Ratio | 20.36 |
| PEG Ratio | 0.39 |
Enterprise Valuation
Medtronic has an Enterprise Value (EV) of 143.77B.
| EV / Earnings | 39.11 |
| EV / Sales | 4.44 |
| EV / EBITDA | 17.53 |
| EV / EBIT | 27.95 |
| EV / FCF | 27.65 |
Financial Position
The company has a current ratio of 2.03, with a Debt / Equity ratio of 0.5.
| Current Ratio | 2.03 |
| Quick Ratio | 1.55 |
| Debt / Equity | 0.5 |
| Total Debt / Capitalization | 33.21 |
| Cash Flow / Debt | 0.27 |
| Interest Coverage | 7.15 |
Financial Efficiency
Return on equity (ROE) is 0.07% and return on capital (ROIC) is 5.15%.
| Return on Equity (ROE) | 0.07% |
| Return on Assets (ROA) | 0.04% |
| Return on Capital (ROIC) | 5.15% |
| Revenue Per Employee | 340.67K |
| Profits Per Employee | 38.69K |
| Employee Count | 95.00K |
| Asset Turnover | 0.36 |
| Inventory Turnover | 2.15 |
Taxes
| Income Tax | 1.13B |
| Effective Tax Rate | 0.23 |
Stock Price Statistics
The stock price has increased by -4.25% in the last 52 weeks. The beta is 0.85, so Medtronic's price volatility has been higher than the market average.
| Beta | 0.85 |
| 52-Week Price Change | -4.25% |
| 50-Day Moving Average | 85.41 |
| 200-Day Moving Average | 84.21 |
| Relative Strength Index (RSI) | 39.08 |
| Average Volume (20 Days) | 5.79M |
Income Statement
In the last 12 months, Medtronic had revenue of 32.36B and earned 3.68B in profits. Earnings per share was 2.77.
| Revenue | 32.36B |
| Gross Profit | 21.15B |
| Operating Income | 5.14B |
| Net Income | 3.68B |
| EBITDA | 8.20B |
| EBIT | 5.14B |
| Earnings Per Share (EPS) | 2.77 |
Balance Sheet
The company has 1.28B in cash and 26.05B in debt, giving a net cash position of -24.76B.
| Cash & Cash Equivalents | 1.28B |
| Total Debt | 26.05B |
| Net Cash | -24.76B |
| Retained Earnings | 30.40B |
| Total Assets | 90.04B |
| Working Capital | 10.24B |
Cash Flow
In the last 12 months, operating cash flow was 6.79B and capital expenditures -1.59B, giving a free cash flow of 5.20B.
| Operating Cash Flow | 6.79B |
| Capital Expenditures | -1.59B |
| Free Cash Flow | 5.20B |
| FCF Per Share | 3.92 |
Margins
Gross margin is 6.53K%, with operating and profit margins of 1.59K% and 1.14K%.
| Gross Margin | 6.53K% |
| Operating Margin | 1.59K% |
| Pretax Margin | 1.50K% |
| Profit Margin | 1.14K% |
| EBITDA Margin | 25.35% |
| EBIT Margin | 15.89% |
| FCF Margin | 16.07% |
Dividends & Yields
MDT pays an annual dividend of $2.8, which amounts to a dividend yield of 3.49%.
| Dividend Per Share | $2.80 |
| Dividend Yield | 3.49% |
| Dividend Growth (YoY) | 1.45% |
| Payout Ratio | 85.63% |
| Earnings Yield | 3.42% |
| FCF Yield | 5.01% |
Analyst Forecast
The average price target for MDT is $93.5, which is 15.5% higher than the current price. The consensus rating is "Hold".
| Price Target | $93.5 |
| Price Target Difference | 15.5% |
| Analyst Consensus | Hold |
| Analyst Count | 15 |
Stock Splits
The last stock split was on Sep 27, 1999. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 1999 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 2.74 |
| Piotroski F-Score | 6 |